Objective To implement the disease prevention and control strategy of being ^"proactive and grassroots-focused,^" and to enhance the overall effectiveness of general hospitals in the tertiary prevention of cervical cancer, this consensus aims to provide an actionable guiding framework for the standardized construction of ^"Integrated Outpatient Clinics for Cervical Cancer Prevention and Control^" in general hospitals at all levels. Methods This consensus systematically elaborates on the specific elements for establishing such integrated clinics and formulates the corresponding standards. Results It is anticipated that the consensus will promote the establishment of standardized, homogeneous, and high-efficiency frontline positions for cervical cancer prevention and control within general hospitals, thereby contributing to the strategic vision of accelerating the elimination of cervical cancer. Conclusion The formulation and promotion of the consensus aim to provide robust clinical practice support for accelerating the realization of China's strategic vision of eliminating cervical cancer.

OBJECTIVE To formulate Expert Consensus on Clinical Application of Inhaled Aminoglycoside Antimicrobials in Lower Respiratory Tract Infections （hereinafter referred to as the “consensus”） in response to the lack of standardized clinical guidelines for the use of inhaled aminoglycoside antimicrobials in the treatment of lower respiratory tract infections， so as to improve the standardization and safety of their clinical application. METHODS Led by Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine， 35 experts in the fields of clinical pharmacy， critical care medicine， respiratory and critical care medicine， and pediatrics in China were convened. Nine clinical practice issues concerning inhaled aminoglycoside antimicrobials were systematically reviewed with domestic and international research evidence and clinical experience. After an in-depth discussion， the consensus was developed. RESULTS The consensus contained 21 recommendations covering nine aspects： therapeutic indications and regimens of inhaled aminoglycosides in different lower respiratory tract infectious diseases （such as bronchiectasis， cystic fibrosis， chronic obstructive pulmonary disease， etc.）， eligible populations and conditions for prophylactic use， principles of empirical use in the absence of definite etiology， strategies for combination therapy versus monotherapy， medication recommendations for special populations （children， patients with renal insufficiency， pregnancy and lactation， etc.）， monitoring and management of adverse reactions， establishment of a physician-pharmacist collaborative management model， selection and standardized use of inhalation devices， and key points of whole-process management and pharmaceutical care. CONCLUSIONS This consensus provides systematic evidence-based guidance for the clinical application of inhaled aminoglycoside antimicrobials in lower respiratory tract infections. It helps standardize clinical practice， optimize dosing regimens， ensure medication safety， and promote the implementation of a multidisciplinary collaborative management model， thereby improving patient outcomes.

Objective To provide scientific and normative guidance for capacity building and quality control standards for vision health management service institutions, thereby promoting the standardization and professional development of the industry, enhancing service quality, and improving the effectiveness of myopia prevention and control. Methods A multidisciplinary expert panel organized by Society of Vision Health Management, Chinese Health Association, based on standards such as the ^"Technical Specifications for Vision Health Management Services for Primary and Secondary School Students^" (T/CHAA 008-2019) and combined with field research data, revised and formed this consensus through multiple rounds of meetings and discussions. Results This consensus clarifies the positioning of service institutions, core service capability requirements (covering basic configuration, personnel and equipment, service processes, scope, and competency levels), and quality control points throughout the service process. It establishes an evaluation framework centered on ^"foundational support - service implementation - management effectiveness - outcome output.^" Conclusion This consensus provides systematic guidance for the standardized construction, capacity evaluation, and quality control of vision health management service institutions, which is of great significance for safeguarding the vision health of children and adolescents.

OBJECTIVE To provide guidance on the scientific and standardized application of artificial intelligence （AI） and multimodal fusion techniques in constructing predictive models for adverse drug reactions （ADR） of antineoplastics， thereby enhancing the safety of antineoplastic therapy. METHODS Jointly initiated by the Clinical Pharmacy and Translational Pharmacy Society of the Liaoning Provincial Life Sciences Association and other professional societies， and organized by the Fourth Affiliated Hospital of China Medical University， the writing group conducted a comprehensive search of domestic and international databases using keywords such as “multimodal data” “artificial intelligence” “adverse drug reactions”“antineoplastics” and “models” to collect guidelines， expert consensuses， and relevant guidance literature. Based on this search， and combined with China’s practical experience in applying AI to oncology pharmaceutical care， a consensus framework and preliminary recommendations were drafted. Following evaluation and discussion by an external expert panel， the writing group incorporated the assessment results and formulated recommendations based on those endorsed by 90% or more of the experts. RESULTS &CONCLUSIONS After multiple rounds of review， discussion and revision， this consensus outlines the process for constructing an ADR prediction model of antineoplastics， encompassing “defining research objectives-data preparation-selection of algorithmic frameworks-design of multimodal data fusion strategies-model training and validation-interpretability analysis-clinical deployment-publication of results”. It also formulates 18 recommendations regarding core aspects such as data preparation， algorithm framwork selection， multimodal data fusion strategy design， model validation and interpretability analysis， and clinical deployment. These recommendations are intended for use by physicians in the field of oncology， clinical pharmacists， researchers， and AI technology developers to assist in making optimal clinical treatment decisions.

OBJECTIVE To provide reference for the closed-loop management of externally purchased medications for inpatients in medical institutions in Shenzhen， thus improve the overall level of pharmaceutical affairs management in medical institutions in Shenzhen. METHODS The relevant guidelines， expert consensus， thematic reviews and policy documents were conducted using keywords such as “ externally purchased drugs”“externally distributed drugs”“externally purchased prescriptions” “externally distributed prescriptions”“closed-loop management” and their corresponding English terms. The initial draft of the Consensus on Closed-loop Management of Externally Purchased Medications for Inpatients in Shenzhen Medical Institutions （shortened for Consensus） was drafted based on the practical experience of the management of externally purchased drugs in medical institutions in Shenzhen. After two questionnaire surveys and four expert symposiums， the Consensus recommendation opinions were formed. RESULTS & CONCLUSION The Consensus covers 10 aspects， including the definition and usage conditions of externally purchased drugs， management organization and informatization construction， principles for catalogue adjustment， catalogue formulation process， prescription issuance and dispensing， return-to-hospital acceptance process， hospital use process and safety management， home pharmaceutical services， supervision and management， as well as principles for prescription dispensing in retail pharmacies and selection of retail pharmacies. It contributes to the improvement of the management of externally purchased medications in medical institution in Shenzhen.

OBJECTIVE To standardize the implementation methods for therapeutic drug monitoring （TDM） of meropenem and ensure the accuracy of TDM results， thereby facilitating the scientific development of individualized treatment regimens for meropenem. METHODS The expert consensus was launched by the Society of Therapeutic Drug Monitoring Pharmacists of Chinese Pharmacists Association. The compilation team comprised experts in clinical pharmacy， TDM technology， and pharmaceutical administration， and it was developed in accordance with the relevant recommendations from the methodology handbook of WHO and the guidelines for TDM guidelines development. Twelve clinical questions were selected through a three- round Delphi voting process conducted by the committee， followed by a comprehensive review of relevant original articles， systematic reviews， and guidelines through general databases. The GRADE approach was employed to evaluate the quality of evidence so as to formulate the consensus recommendations. The experts’ opinions were organized， revised and finally formed into a consensus. RESULTS Ultimately， the consensus presented 14 recommendations， mainly regarding all aspects of TDM processes including necessity， method， monitor timing， target PK/PD， medication adjustments based on PK/PD， and the quality control of TDM. CONCLUSIONS This consensus provides standardized methods and process suggestions for meropenem TDM in medical institutions in China， and is of great significance for meropenem individualized drug use， improving clinical efficacy， and ensuring drug safety.

Objective To provide front-line practitioners with evidence-based guidelines for rapidly estimating the workload of mosquito control operations during mosquito-borne diseases outbreaks,to establish effective response strategies,and to facil-itate efficient deployment of human and material resources. Methods Under the auspices of the Preventive Medicine As-sociation of Hubei Province,a panel of experts was convened to develop the framework for this consensus. The drafting com-mittee conducted a systematic analysis and synthesis of field-based practices relevant to the outlined topics. The document was subsequently reviewed,debated,and refined through multiple rounds of discussions by experts from the Association's Committees on Disinfection & Vector Control and Epidemiology before finalization. Results This consensus document pro-vides recommendations on mosquito control methodologies, labor time estimation, operational organization, implementation strategies,as well as effectiveness evaluation and continuous improvement. Conclusion It offers a scientific basis for e-mergency mosquito control workload calculation and proposes standardized management protocols for organizing response ef-forts. This consensus is instrumental in guiding and improving the control of mosquito-borne diseases across diverse regions.

OBJECTIVE To provide reference for further unifying and standardizing the quality of home-based pharmaceutical services in close-knit regional medical community of Sichuan and Chongqing， and ensuring medication safety of patients. METHODS Under the guidance of the Chongqing Medical Association and the Chongqing Pharmaceutical Administration Quality Control Center， and led by the Bishan Hospital Affiliated to Chongqing Medical University and the Yongchuan Hospital Affiliated to Chongqing Medical University， 14 medical institutions in the Sichuan-Chongqing region jointly participated. Based on existing regulations， guidelines， and expert consensus， questionnaire survey was conducted to investigate the implementation status of home- based pharmaceutical services within the close-knit regional medical community of Sichuan and Chongqing. Subsequently， the Delphi method was employed for expert consultation and the analytic hierarchy process was used to determine indicator weights， ultimately establishing a quality control system for home-based pharmaceutical services in the close-knit regional medical community of Sichuan and Chongqing. RESULTS & CONCLUSIONS This consensus has established a quality control system for home-based pharmaceutical services within the close-knit regional medical community of Sichuan and Chongqing， encompassing three dimensions： service qualification evaluation， necessity evaluation， and service quality evaluation. Among them， service quality evaluation serves as the core component of the quality control system， incorporating 16 secondary indicators， which are further classified into 9 core indicators and 7 general indicators based on their significance. Meanwhile， this consensus proposes a phased quality control strategy. Under the framework of the close-knit regional medical community in Sichuan and Chongqing， this strategy takes execution priority and execution effectiveness as 69 its core. It allows for flexible handling of the rigid requirements concerning service qualifications and necessity， thereby providing a unified and operable quality control toolkit for the close-knit regional medical community in Sichuan and Chongqing.

OBJECTIVE To promote the rational use of phosphatidylinositol 3-kinase （PI3K）/protein kinase B （Akt）/ mammalian target of rapamycin （mTOR） inhibitors in breast cancer treatment and provide guidance for pharmacists to implement homogeneous medication therapy management. METHODS A multidisciplinary panel comprising content experts （clinical medicine， pharmacy） and methodological experts （evidence-based medicine， statistics， medical ethics） was assembled using the Nominal Group Technique. A draft consensus was developed through systematic literature retrieval， analysis， and synthesis. External reviewers evaluated the draft via questionnaire-based feedback and revisions were incorporated to finalize the consensus. RESULTS This consensus framework focuses on the medication therapy management process of PI3K/Akt/mTOR inhibitors with information collection， treatment regimen evaluation and pharmaceutical intervention structure modules. Seven critical issues and eight evidence-based recommendations were addressed， including efficacy assessment， drug selection， safety， drug interactions， and adherence. CONCLUSION This consensus offers comprehensive medication guidance on PI3K/Akt/mTOR inhibitors in the treatment of breast cancer for pharmacists， aiming to enhance therapeutic effectiveness in patients， reduce the incidence of adverse reactions， and ensure the safe and effective use of medications.

With the aging population and the increasing prevalence of chronic non-communicable diseases,the burden of endocrine and metabolic diseases has become substantial and represents a significant portion of medical insurance management and fund expendi-tures.Since the introduction of the basic medical insurance outpatient special disease protection policy in Chongqing in 2002,23 years have passed.During this period,the evidence base for relevant diseases has gradually expanded,and the concepts of diagnosis and treatment,as well as therapeutic technologies,have undergone considerable updates and transformations.The existing medical insur-ance policy urgently needs to be updated to keep pace with modern medical advancements and to provide patients with more advanced and effective medical security services.Therefore,starting from June 1,2025,the Medical Insurance Bureau of Chongqing Municipal-ity will implement a new medical insurance policy reform.To ensure the smooth implementation and operation of this policy,the Endo-crinology and Diabetes Branches of the Medical Association of Chongqing Municipality have organized experts in endocrine metabo-lism and public health.Under the guidance of the Medical Insurance Bureau,these experts have interpreted the new policies related to the diagnostic criteria and reimbursement scope for outpatient special diseases in the field of endocrine metabolism.By integrating the latest guidelines for endocrine and metabolic diseases with the ac-tual medical practice in Chongqing,and through multiple rounds of expert discussions that combine clinical experience with medical in-surance management insights,a consensus has been reached on key aspects such as the reimbursement directory for outpatient spe-cial diseases,optimization of disease diagnostic pathways,and the implementation of standardized diagnosis and treatment protocols.This consensus aims to promote the establishment of a standardized management system.The goal is to enhance the efficiency of medical insurance fund utilization and the rate of disease management achievement,to standardize diagnostic and treatment practices,to curb unreasonable medical expenditures,and to ensure that medical insurance funds are precisely allocated to improve patients'quality of life.This initiative will help achieve full life cycle management of chronic diseases,support the comprehensive implementation of the"Healthy China 2030"action plan in Chongqing,and provide a regional practice reference for the national medical insurance reform.